%Second Table: Part 1
\begin{landscape}
\begin{table}[p]
\scriptsize
\centering
\caption[Autophagy modulation in \textit{in vivo} models of neurodegenerative diseases]{Autophagy modulation in \textit{in vivo} models of neurodegenerative diseases}
\label{tab:table2}
\begin{tabular}{llcccccccc}
\toprule
 & Autophagy modulators & FDA-approved & Disease model & Mutant protein & Brain region (cell type) & Dose & \textbf{cont.} \\
\midrule
 & \multirow{6}{*}{Rapamycin} & \multirow{6}{*}{Yes} & \multirow{6}{*}{AD} & Tau & Eyes & 1 muM & \multirow{6}{*}{\textbf{1}} \\
\multirow{5}{*}{mTOR dependent} & & & & APP & Hippocampus & 2.24 mg/kg &\\\cmidrule{5-7}
 & & & & \multirow{2}{*}{\makecell{PS1\textsubscript{M146V}/APP\textsubscript{swe}/\\Tau\textsubscript{P301L}}} & \makecell{Cortical areas (peri-rhinal cortex) \& \\Hippocampus (CA1 pyramidal neurons)} &14 mg/kg & \\\cmidrule{6-7}
 & & & & & Hippocampus (CA1 pyramidal neurons) & 2.24 mg/kg & \\\cmidrule{2-8}
 & Temsirolimus (CCI-779) & Yes & AD & Mo/HuAPP\textsubscript{695}/ PS1\textsubscript{dE9} & Hippocampus and cerebral cortex & 20 mg/kg & \textbf{2} \\\cmidrule{1-8}
\multirow{9}{*}{mToR independent} & \multirow{2}{*}{Lithium} & \multirow{2}{*}{Yes} & \multirow{2}{*}{AD} & Tau\textsubscript{P301L} & \makecell{Left and right hemisphere \& \\anterior horn of the spinal cord} & 2g/kg \& 1g/kg & \multirow{2}{*}{\textbf{3}} \\
 & & & & ABPP\textsubscript{SWE}/PS1\textsubscript{A246E} & Cortex \& Hippocampus & 0.18 mmol & \\\cmidrule{2-8}
 & \multirow{2}{*}{Carbamazepine} & \multirow{2}{*}{Yes} & \multirow{2}{*}{AD} & APP\textsubscript{swe}/PS1\textsubscript{deltaE9} & Cortex \& Hippocampus & \multirow{2}{*}{100 mg/kg} & \multirow{2}{*}{\textbf{4}} \\
 & & & & 3x Tg & Hippocampus & & \\\cmidrule{2-8}
 & \multirow{2}{*}{Trehalose} & \multirow{2}{*}{No} & \multirow{2}{*}{Tauophathy} & \multirow{2}{*}{Tau} & \makecell{Cerebral cortex layer I-III, \\ brainstem e.g pontine nucleus} & 0.02 & \multirow{2}{*}{\textbf{5}} \\
 & & & & & \makecell{Hippocampus, cortex, \\striatum, sustantia nigra} &0.01 & \\\cmidrule{2-8}
 & \multirow{2}{*}{Rilmenidine} & \multirow{2}{*}{Yes} & HD & Htt & \makecell{Periform cortex, motor cortex \& \\ hippocampus} & \multirow{2}{*}{10 mg/kg} & \multirow{2}{*}{\textbf{6}} \\
 & & & ALS & SOD1 & Spinal cord e.g spinal motor neurons & & \\\cmidrule{2-8}
 & \multirow{2}{*}{Spermidine} & \multirow{2}{*}{Yes} & FLD & TDP-43 & Cortex \& Hippocampus & 50 mg/ml & \multirow{2}{*}{\textbf{7}}\\
 & & & PD & $\alpha$-synuclein & Dopaminergic neurons & 5 mM & \\
\bottomrule
\end{tabular}
\end{table}
\end{landscape}

%Second Table: Part 2
\begin{landscape}
\begin{table}[p]
\scriptsize
\centering
\caption*{Autophagy modulation as a therapy in \textit{in vivo} models of neurodegenerative diseases \textbf{\textit{(continued)}}}
\begin{tabular}{cccccccc}
\toprule
\textbf{cont.} & Duration & Basal flux & \makecell{Induced flux \\inhibition} & \makecell{Assessment for \\aggregation} & \makecell{Assessment for \\autophagy} & References \\
\midrule
\multirow{8}{*}{\textbf{1}} & - & - & - & LM (Tau) & - & \citet{Berger2006} \\\cmidrule{5-6}
& \makecell{everyday for \\13 weeks} & - & - & \makecell{WB (AB40/42, APP),\\ Elisa (AB40/42)} & \makecell{WB (LC3II \& p62),\\ FM (LC3 II)} & \citet{Spilman2010} \\\cmidrule{5-6}
& \makecell{everyday for 3, \\16 months} & - & - & \makecell{WB (APP), FM, LM \& \\ELISA (AB40/42), LM \& WB (Tau) \& \\WB (APP, C99, C88 \& tau)} & \makecell{WB (LC3 II, ATG7, ATG 5/ \\ATG 12), EM (Autophagosomes)} & \citet{Majumder2011} \\\cmidrule{5-6}
& \makecell{everyday for \\10 weeks} & - & - & \makecell{ELISA (AB40/42), \\WB, FM, LM \& ELISA (Tau) \& \\ WB (APP, C99, C88 \& tau)} & \makecell{WB (LC3 I, II, ATG7, \\ATG 5/ ATG 12)} & \citet{Caccamo2010} \\\cmidrule{1-7}
\textbf{2} & \makecell{every 2 days \\for 60 days} & - & - & \makecell{LM (AB plaques), \\ELISA (AB40/42) \& \\WB (APP, C99 \& C88)} & \makecell{WB (LC3II \& p62), \\TEM (autophagosomes)} & \citet{Jiang2014a} \\\cmidrule{1-7}
\multirow{2}{*}{\textbf{3}} & \makecell{everyday for 2 months \\with 2g, everyday \\ for 2 months with 1g \\(total of 4 months)} & - & - & WB \& LM (Tau) & \makecell{LM \& FM (LC3) \& \\WB (p62)} & \citet{Shimada2012} \\
& \makecell{everyday for \\3 months} & - & - & \makecell{ELISA, FM \& \\WB (AB40/42) \& \\WB (APP, BACE1,C99, \\ C88 \& tau)} & WB \& FM (LC3) & \citet{Zhang2011} \\\cmidrule{1-7}
\multirow{2}{*}{\textbf{4}} & everyday & - & - & \makecell{FM \& LM (AB plaques), \\ELIZA (AB42), \\WB (APP, BACE1,Alp1a)} & \makecell{WB (LC3 II, p62), \\FM (LC3)} & \citet{Li2013} \\
& \makecell{everyday for \\2 months} & - & - & \makecell{LM (AB plaques) \& \\ELIZA (AB40 \&42)} & WB (LC3 II) & \citet{Zhang2017} \\\cmidrule{1-7}
\multirow{2}{*}{\textbf{5}} & \makecell{2x a week for \\4 months} & - & - & \makecell{WB (tau) \& FM \\(tau, AT100 positive inclusions)} & WB \& FM (LC3 II, p62) & \citet{Schaeffer2012} \\
& \makecell{2x a week for \\2.5 months \& 4 months} & - & - & \makecell{FM, LM (AB plaques) \& \\ WB (tau)} & \makecell{WB, FM (LC3 II, p62,) \& \\EM (AVs)} & \citet{Rodriguez-Navarro2010} \\\cmidrule{1-7}
\multirow{2}{*}{\textbf{6}} & \multirow{2}{*}{4x a week for 24 weeks} & - & - & FM \& WB (htt ) & WB (LC3) & \citet{Rose2010} \\
& & - & - & FM \& WB (SOD1) & \makecell{WB (LC3 II, p62, \\LAMP2A, VDAC1, \\HSPA8) \& FM (LC3 \& \\LAMP2A)} & \citet{Perera2018} \\\cmidrule{1-7}
\multirow{3}{*}{\textbf{7}} & 3x a week for 30 days & - & - & FM (TDP-43) & WB (LC3 II and p62) & \citet{Wang2012} \\
& 24 and 48 h & - & - & WB ($\alpha$-synuclean) & WB (LC3 II) & \multirow{2}{*}{\citet{Buttner2014}} \\
& - & - & - & FM ($\alpha$-synuclean) & FM (LGG-1) \\
\bottomrule
\end{tabular}
\end{table}
\end{landscape}